Zhongsheng Pharmaceutical announced that the company recently received the “Drug Supplement Application Approval Notice” for fenofibrate capsules approved and issued by the State Drug Administration, agreeing to approve the supplementary application to increase the 0.2 g specification, and issued the drug approval number Sinopharm Standard H20269221, which is deemed to have passed the consistent evaluation of the quality and efficacy of generic drugs.

Zhongsheng Pharmaceutical announced that the company recently received the “Drug Supplement Application Approval Notice” for fenofibrate capsules approved and issued by the State Drug Administration, agreeing to approve the supplementary application to increase the 0.2 g specification, and issued the drug approval number Sinopharm Standard H20269221, which is deemed to have passed the consistent evaluation of the quality and efficacy of generic drugs.